<- Go Home
Protia Inc.
Protia Inc. manufactures and sells in vitro diagnostic medical devices in South Korea. It offers allergy, animal diagnosis, autoimmune, antibiotic susceptibility, POCT, cancer, and related instrument products, as well as protein analysis, LC-MS/MS, characterization analysis, and custom protein services. The company was formerly known as ProteomeTech Inc. and changed its name to Protia Inc. in November 2023. Protia Inc. was founded in 2000 and is headquartered in Seoul, South Korea.
Market Cap
KRW 62.9B
Volume
107.2K
Cash and Equivalents
KRW 3.1B
EBITDA
KRW 5.2B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
KRW 10.9B
Profit Margin
61.46%
52 Week High
KRW 6.9K
52 Week Low
KRW 3.7K
Dividend
N/A
Price / Book Value
1.90
Price / Earnings
11.49
Price / Tangible Book Value
1.91
Enterprise Value
KRW 49.2B
Enterprise Value / EBITDA
9.55
Operating Income
KRW 4.7B
Return on Equity
18.04%
Return on Assets
8.96
Cash and Short Term Investments
KRW 13.9B
Debt
KRW 226.4M
Equity
KRW 33.2B
Revenue
KRW 17.7B
Unlevered FCF
-KRW 3.5B
Sector
Health Care Equipment and Supplies
Category
N/A